Our Products

Letrozole Tablets USP 2.5 mg is a medication used primarily in the treatment of hormone receptor-positive breast cancer in postmenopausal women. It is an aromatase inhibitor, which works by inhibiting the aromatase enzyme responsible for the conversion of androgens into estrogen. Since some breast cancers grow in response to estrogen, lowering estrogen levels can help slow or stop the growth of these cancers.

The 2.5 mg dosage is typically taken once daily, as prescribed by a healthcare provider, often following surgery or radiation therapy to reduce the risk of cancer recurrence. Common side effects of Letrozole include hot flashes, joint pain, fatigue, and an increased risk of osteoporosis. Regular monitoring, including bone density tests, is recommended during treatment.